InflaRx

NCT02246595

Studying Complement Inhibition in Early, Newly Developing Septic Organ Dysfunction

NCT02866825

Studying Complement Inhibition in Complex Cardiac Surgery

NCT03001622

Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa

NCT03487276

Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT03712345

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA

NCT03895801

Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

NCT03971643

Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum

NCT04812535

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

NCT06555328

Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

NCT06701656

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

NCT06701669

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

NCT06703073

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

NCT06701682

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab